Abstract
OBJECTIVE. A multimodality imaging spectrum of adrenocortical carcinoma, with an emphasis on both anatomic and functional imaging, will be reviewed. Recent advances in the molecular cytogenetics of this tumor and its impact on diagnosis, prognosis, and development of newer targeted therapy will be discussed in this article. CONCLUSION. Adrenocortical carcinomas are rare aggressive tumors associated with a poor prognosis. Awareness of the molecular behavior and spectrum of imaging features of this tumor can help in appropriate patient treatment.
Original language | English (US) |
---|---|
Pages (from-to) | 1283-1293 |
Number of pages | 11 |
Journal | American Journal of Roentgenology |
Volume | 199 |
Issue number | 6 |
DOIs | |
State | Published - Dec 2012 |
Keywords
- Adrenocortical carcinoma
- CT
- FDG PET/CT
- MRI
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging